Though many local veterinarians voiced opposition once again, the California Horse Racing Board approved the third-party administration of race-day Lasix June 16 during a meeting at Santa Anita Park.
In a presentation at the RCI conference March 23 in New Orleans, Jockey Club executive director Matt Iuliano highlighted studies examining the efficacy of administering furosemide at least 24 hours before a race.
The AAEP has identified areas it believes are central to understanding exercise-induced pulmonary hemorrhage, and it hopes they determine future research into alternative methods of combating EIPH.
A study designed to determine the levels of exercise-industry pulmonary hemorrhage in 2-year-olds racing in South Florida is complete, but the data won't be released until a scientific paper is published after peer review.
Kentucky attorney general finds KHRC lacked authority to allow Lasix-free races, which could hinder Keeneland's plans to conduct such events in 2016.
The pre-race protocol of Thoroughbreds racing at Remington Park in 2016 will include a quick stop on a scale where their weight will be recorded and that information will be provided to the public before the race.
The furosemide industry is a $3 million annual business for Thoroughbred racing in New York state, regulators said Oct. 26, with the average horse given $500 worth of doses in a typical year.
A Thoroughbred Owners and Breeders Association committee has renewed talks regarding a proposal to phase out use of race-day furosemide in graded stakes.
Churchill Downs announced Sept. 17 that it is working in partnership with other tracks, the Grayson-Jockey Club Research Foundation, and the AAEP to fund studies of the administration of furosemide.
In a survey designed to combat claims that the leaders of horsemen's groups don't represent their membership, the Florida HBPA Sept. 16 released the results of a poll that said most respondents support use of Lasix.
Nearly a month after the California Horse Racing Board hit the brakes on third-party administration of furosemide in the state, the governing body spent just more than a minute to move the process along at a meeting Sept. 16.
Two research projects designed to study the impact of furosemide on exercise-induced pulmonary hemorrhage will be conducted on behalf of the Grayson-Jockey Club Research Foundation, the organization said Sept. 15.
The Administrative Regulation Review Subcommittee of the Kentucky legislature has voted 6-2 to find a proposed regulation permitting racetracks the option of carding furosemide-free races "deficient."
With an eye toward a possible proposal to change New York's rules on the race-day medication furosemide, the state's Gaming Commission met in Saratoga Springs Aug. 25 to solicit opinions about the medication.
At a forum designed to educate state regulators about furosemide, the very people the presentations were designed to enlighten may well have left with more questions than answers.
Two days after delaying steps to begin third-party administration of race-day furosemide, members of the California Horse Racing Board said they're still in support -- in concept -- of the proposal.
The Coalition for Horse Racing Integrity said Aug. 21 California's failure to adopt third-party administration of the race-day drug furosemide shows the pitfalls of state-by-state regulation.
Use of race-day furosemide will be the topic for a daylong forum put together by the New York State Gaming Commission Aug. 25 in Saratoga Springs, N.Y.
The opening panel Aug. 11 at the Saratoga Institute on Racing, Equine, and Gaming Law conference set the tone for what figures to be a continued industry battle over federal versus state-by-state regulation.
The American Association of Equine Practitioners has released a "Prescription for Racing Reform" that includes "a commitment to identifying non-race day treatment alternatives for exercise-induced pulmonary hemorrhage."
A Salix-free race proved so popular at the entry box Wednesday that the over-subscribed field of 2-year-old fillies was split into two races for Saturday's program at Gulfstream Park.
Considering possible changes to the state's equine drug laws, New York regulators are calling together education, veterinary science, and industry experts to discuss the use of the anti-bleeding medicine furosemide.
Gulfstream Park in July plans to experiment with at least two 2-year-old races that will be written for horses that don't compete on race-day furosemide, officials said June 11.
- By Tom LaMarra
United States Rep. Paul Tonko of New York said May 29 he will introduce federal legislation that would grant the United States Anti-Doping Agency oversight of equine medication and drug testing.
The Kentucky Equine Drug Research Council will advise the Kentucky Horse Racing Commission to adopt policies on the mineral cobalt in line with a Racing Medication and Testing Consortium recommendation.
A May 6 vote to change the recommended testing threshold for the anti-bleeding medication furosemide when it is administered 24 hours before a race triggered another debate and posed more questions.
Owner Bill Casner hasn't wavered since his 2011 decision to race his Thoroughbreds without the widely used diuretic furosemide, or Salix (Lasix).
Mubtaahij has never raced on the anti-bleeding medication Lasix, and he will run without it in the Kentucky Derby, becoming the first horse in 10 years to do so.
Trainer Michael Dickinson explains why he has joined the ranks of WHOA members working to pass federal legislation to prohibit the use of performance-enhancing drugs in North American horse racing.
The Kentucky Horse Racing Commission March 23 approved a regulation that would permit the state's racetracks to card races that would prohibit the administration of furosemide within 24 hours of post time.
New York regulators March 23 said they want to hold a forum to consider the future use of anti-bleeding medication furosemide in the state.
The Kentucky Horse Racing Commission is considering a proposal that would permit the state's racetracks to card races that would prohibit the administration of furosemide within 24 hours of post time.
Kentucky Equine Research president Joe Pagan, Ph.D., will discuss proper nutrition for horses being treated with Lasix (furosemide, formally called Salix) at a March 16 seminar in Ocala, Fla.
Legislation governing equine medication policy is scheduled to be heard Feb. 18 by the Florida Senate Regulated Industries Committee.
Rivals and racing fans may view top trainer Todd Pletcher as reserved and unemotional, but there is more to the dedicated horseman than meets the eye. A competitive nature, sly wit, and drive to succeed have carried him to the top of the game.
The RMTC said Dec. 9 the Thoroughbred industry has made "major gains" this year in the number of jurisdictions operating or soon to be operating under all or part of the National Uniform Medication Program.
Gulfstream Park will begin third-party administration of race-day furosemide beginning Wednesday, Nov. 19.
Ogden Phipps said Oct. 6 a centralized regulatory body for horse racing would facilitate changes necessary to improve the integrity of the sport in the United States, but the chances of it happening are slim to none.
Charles J. Cella, president of Oaklawn Racing & Gaming, announced Sept. 18 that the Arkansas track in 2015 will offer purse bonuses for horses that run and win without furosemide (Salix or commonly called Lasix).
Jockey Club says a recent study's findings challenge long-held opinions in North American racing, including the contention that the use of the diuretic furosemide is necessary to ensure long-term careers of horses.
A study published online this spring found no link between the vast majority of horses who suffer from exercise-induced pulmonary hemorrhage and long-term racing performance.
A Kentucky racing official Sept. 12 said the state has been at the forefront of research into cobalt, a naturally occurring element said to have blood-doping qualities if used at high levels.
Kentucky regulators are considering allowing tracks in the state to card races that would prohibit the administration of race-day furosemide, commonly called Salix or Lasix.
The National Horsemen's Benevolent and Protective Association restated its strong support for the continued use of Lasix (furosemide, also commonly called Salix) at its summer convention Aug.15-17 in Oklahoma City.
In response to a statement from 25 prominent horsemen calling for a ban on the race-day use of furosemide, the Florida Horsemen's Benevolent and Protective Association Aug. 8 issued an open letter opposing changes.
In response to several top trainers calling for the end of race-day furosemide, horsemen's groups throughout the country say they will continue to support the use of the diuretic to prevent or reduce the severity of EIPH.
Eliminating race-day Salix is gaining momentum. read blog
Some of North America's top trainers are backing a plan to eliminate the use of race-day medication in the U.S. beginning next season with 2-year-olds, and expanding to all horses in 2016.
A new study finds no difference in the racing career longevity between horses who experience some level of exercise-induced pulmonary hemorrhage and those who never experience EIPH.
Multiple racing jurisdictions have adopted all or parts of the National Uniform Medication Program, with others expected to be on board by the end of this year.
Most Popular Stories
- Dortmund Drills for Sherman at Los Al
- Bayern's First Foal, a Filly, Arrives in Ontario
- Stronach Still Seeking New Heights for Racing
- Jockey Olguin Secures Milestone Win
- Stonestreet to Sponsor Lexington Stakes, Purse Boosted
- Uncontested Romp in Smarty Jones
- R. A. Hill Stable Buys Into Breaking Lucky
- The Curse of Haskin
- Metaboss to Harris Farms in California
- First Foal by American Pharoah Born at Brookdale Farm